Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Introduced in 1994, rocuronium has rapid onset, and intermediate duration of action. It is commonly marketed under the trade names Zemuron and Esmeron. The drug is associated with the risk of developing allergic reactions in some high-risk patients, such as those with asthma. However, there was a similar incidence of allergic reactions associated with other non-depolarizing neuromuscular blocking agents. Sugammadex is a γ-cyclodextrin derivative that has been introduced as a novel agent to reverse the action of rocuronium.
Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Introduced in 1994, rocuronium has rapid onset, and intermediate duration of action. It is commonly marketed under the trade names Zemuron and Esmeron. The drug is associated with the risk of developing allergic reactions in some high-risk patients, such as those with asthma. However, there was a similar incidence of allergic reactions associated with other non-depolarizing neuromuscular blocking agents. Sugammadex is a γ-cyclodextrin derivative that has been introduced as a novel agent to reverse the action of rocuronium.
For inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
To view more clinical trials, please log in to your account.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2015/06/15 | Not Applicable | Completed | |||
2015/06/12 | Phase 2 | Completed | |||
2015/06/10 | Phase 4 | UNKNOWN | |||
2015/06/08 | Phase 4 | UNKNOWN | |||
2015/05/21 | Phase 4 | Completed | |||
2015/04/13 | Phase 4 | Completed | |||
2015/04/07 | Phase 4 | Withdrawn | |||
2015/03/27 | Not Applicable | Completed | |||
2015/03/19 | Phase 2 | UNKNOWN | |||
2015/03/03 | N/A | Completed |
To view more FDA approved products, please log in to your account.
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
To view more EMA approved products, please log in to your account.
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
To view more Singapore approved products, please log in to your account.
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No Singapore products found for this drug
To view more China approved products, please log in to your account.
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|
No China products found for this drug
To view more Australia approved products, please log in to your account.
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No Australia products found for this drug